Evidence map›Paper›PMID 25992863›Full record

ArticleImmunity2015

Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.

Wong Yu, Ning Jiang, Peter J R Ebert, Brian A Kidd, Sabina Müller, Peder J Lund, Jeremy Juang, Keishi Adachi, Tiffany Tse, Michael E Birnbaum and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 200 papers.

0numbers the graph read from it
0cells of the map it votes in
200citing papers in PubMed
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

200 citing papers in PubMed, 290 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. CD8Nature reviews. Cardiology · 2026
    Review
  5. Review
  6. CD8 T Cell Sensing of Type I Interferon Impacts Anergy.European journal of immunology · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

140 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Wong YuDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Ning JiangDepartment of Bioengineering, Stanford University School of Medicine, Stanford, CA 94305, USA.
Peter J R EbertDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Brian A KiddDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sabina MüllerINSERM, UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France and Université Toulouse III Paul-Sabatier, 31024 Toulouse, France.
Peder J LundDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jeremy JuangDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Keishi AdachiDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Tiffany TseDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Michael E BirnbaumDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Evan W NewellDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Darrell M WilsonDepartment of Pediatric Endocrinology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Gijsbert M GrotenbregWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Salvatore ValituttiINSERM, UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France and Université Toulouse III Paul-Sabatier, 31024 Toulouse, France.
Stephen R QuakeDepartment of Bioengineering, Stanford University School of Medicine, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Mark M DavisDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: mmdavis@stanford.edu.
Stanford University · USHoward Hughes Medical Institute · USUniversité Toulouse III - Paul Sabatier · FRWhitehead Institute for Biomedical Research · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2010 to 2015
$17.3M
Genomic Approaches to the T Cell Receptor Repertoire during AgingR00AG040149 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI JIANG, NING JENNY · 2013 to 2015
$740k
Tolerance mechanisms in self reactive T cells in healthy people and type 1 diabetK08DK093709 · NIDDK · STANFORD UNIVERSITY · PI WONG, YU · 2011 to 2013
$395k
Howard Hughes Medical InstituteNIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI090019NIAID NIH HHS U19-AI090019NIAID NIH HHS U19-AI57229NIA NIH HHS R00 AG040149NIA NIH HHS R00AG040149NIDDK NIH HHS 1K08DK093709-01NIDDK NIH HHS K08 DK093709
6 · The paper itself

Abstract

It has long been thought that clonal deletion efficiently removes almost all self-specific T cells from the peripheral repertoire. We found that self-peptide MHC-specific CD8(+) T cells in the blood of healthy humans were present in frequencies similar to those specific for non-self antigens. For the Y chromosome-encoded SMCY antigen, self-specific T cells exhibited only a 3-fold lower average frequency in males versus females and were anergic with respect to peptide activation, although this inhibition could be overcome by a stronger stimulus. We conclude that clonal deletion prunes but does not eliminate self-specific T cells and suggest that to do so would create holes in the repertoire that pathogens could readily exploit. In support of this hypothesis, we detected T cells specific for all 20 amino acid variants at the p5 position of a hepatitis C virus epitope in a random group of blood donors.

Indexed as

Clonal DeletionAnimalsAntigenic VariationCD8-Positive T-LymphocytesFemaleFlow CytometryHumansMaleMiceReceptors, Antigen, T-Cell, alpha-betaSelf ToleranceReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID25992863
PMCPMC4455602
OpenAlexW1536222681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.